Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation.
about
Idiopathic juxtafoveolar retinal telangiectasis: a current reviewThe combination of intravitreal triamcinolone and phacoemulsification surgery in patients with diabeticfoveal oedema and cataract.The role of aflibercept in the management of diabetic macular edemaIntravitreal triamcinolone as a primary therapy in diabetic macular oedema.Intravitreal triamcinolone acetonide for treatment of persistent macular oedema in branch retinal vein occlusion.Trans-Tenon's retrobulbar triamcinolone acetonide infusion for refractory diabetic macular edema after vitrectomy.Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema.Laser photocoagulation combined with intravitreal triamcinolone acetonide injection in proliferative diabetic retinopathy with macular edema.Intravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edema.UK national survey of current practice and experience of intravitreal triamcinolone acetonide.Rapid reduction of hard exudates in eyes with diabetic retinopathy after intravitreal triamcinolone: data from a randomized, placebo-controlled, clinical trial.Role of steroids in the management of diabetic macular edema and proliferative diabetic retinopathy.Comparison of photocoagulation with combined intravitreal triamcinolone for diabetic macular edema.Steroid injection in addition to macular laser grid photocoagulation in diabetic macular oedema: a systematic review.Triamcinolone-induced cataract in eyes with diabetic macular oedema: 3-year prospective data from a randomized clinical trial.Antiangiogenic drugs in the management of ocular diseases: Focus on antivascular endothelial growth factorBehavior of intraocular pressure after intravitreal injection of triamcinolone acetonide among egyptians.Comparison of intravitreal triamcinolone treatment and intravitreal triamcinolone with grid laser treatment in patients with diffuse diabetic macular edema.Central retinal vein occlusion: a review.Role of vascular endothelial growth factor in the breakdown of the blood-aqueous barrier after retinal laser photocoagulation in pigmented rabbits.Intravitreal triamcinolone versus laser photocoagulation as a primary treatment for diabetic macular oedema--a comparative pilot studyA prospective, randomized comparison of intravitreal triamcinolone acetonide versus intravitreal bevacizumab (avastin) in diffuse diabetic macular edema.Corticosteroid use for diabetic macular edema: old fad or new trend?Intravitreal versus subtenon triamcinolone acetonide injection for diabetic macular edema: a systematic review and meta-analysis.IVTA as adjunctive treatment to PRP and MPC for PDR and macular edema: a meta-analysis.Comparison of intravitreal bevacizumab, intravitreal triamcinolone acetonide, and macular grid augmentation in refractory diffuse diabetic macular edema: A prospective, randomized study.Glucocorticoid induction of occludin expression and endothelial barrier requires transcription factor p54 NONOFluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema.The management of retinal vein occlusion: is interventional ophthalmology the way forward?Lymphatics and lymphangiogenesis in the eye.The combination of phacoemulsification surgery and intravitreal triamcinolone injection in patients with cataract and diabetic macular edemaMacular laser photocoagulation with or without intravitreal triamcinolone pretreatment for diabetic macular edema: a result from five randomized controlled trials.Therapeutic Options in Refractory Diabetic Macular Oedema.Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.The pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema.Ocular morbidity associated with intravitreal triamcinolone acetonide.Posterior subtenon triamcinolone acetonide in gas-filled eyes as an adjunctive treatment for complicated proliferative diabetic retinopathy.Outcome of intravitreal triamcinolone acetonide in postoperative cystoid macular oedema.Intravitreal triamcinolone acetonide for the management of papillophlebitis and associated macular edema.Twelve months of follow-up after intravitreal injection of ranibizumab for the treatment of idiopathic parafoveal telangiectasia.
P2860
Q24616761-5B72DEE0-9033-4FF1-98F6-740B8061231BQ24810825-C74E3494-275C-446C-8D83-7A9BFF48BD92Q26798348-56B1FFFF-94D9-484C-A841-22408CBF4E0AQ33205922-CA060B27-38F1-4ADB-9B06-434A4FE0098EQ33212148-C353E29C-9DB8-457D-97E3-B6E604AB1AF2Q33219602-7C219BD9-1006-48CC-A646-6D02B740780AQ33282544-87B0AD40-AE8C-4ED0-B545-60B06D963804Q33282848-1C8B374F-D0C9-4117-AB35-7880C2784F92Q33325652-5B5D7569-EDB8-4291-822F-3DA781713A93Q33343431-72539E0F-145B-4FEE-A8F4-16E49A039C2EQ33368822-885996A3-034B-402B-9BD8-BE2296398736Q33431322-1A6B7973-15E4-47D1-B4C0-147D59A32DBDQ33507910-0A46A9CD-4651-4A27-9D30-B239BF43A49AQ33539977-A739E69A-CEF3-421C-9DF3-8B74B25D1CF2Q33596532-20614E8E-4E87-453E-9BD1-0A0B282E8CA2Q33819829-601D5FD8-41DA-4E57-A62C-7D38D5CC8194Q33939208-83C939F2-2614-4175-986A-4DE58B13B25CQ33973609-C8B36152-FEA6-4C87-AB11-80541F8D6126Q34049493-A062AD47-37CC-47BE-B039-D866D350210EQ34051527-AF4086A8-9595-4009-8FA3-97B90F20D4ABQ34082086-02AD6FAF-3689-47D6-9FFA-22BF2C8017E3Q34107543-E13D0B14-6CC4-4A58-9E53-A40337776410Q34267270-7F0D372B-3FA6-4585-97F9-AD1086B286E6Q34336983-01C8B98F-E582-42E6-8BAD-AE1BF338B2A4Q34413735-091E9E9B-DAF8-46B4-9EAA-A875D2EB7C51Q34601246-10D991AC-CDC1-41F3-B0E8-F73F055EDD2DQ34703697-10012D95-B395-468B-92CE-EDCE559B03DFQ34758061-50F9C73D-5976-42CA-9A9D-EF8AF1C28C83Q35761801-FBEB1025-5C19-4630-923C-899FFCEAA407Q35864976-6AC20901-E153-41E8-AECB-4EA70056626AQ35947430-BBFAC134-DCD8-484D-B59A-6D4FA386308BQ35947505-72402D3D-4332-424B-9D0A-6BABD3E748FEQ36280656-82305D86-1FE4-4B17-9F2F-247BA91967DFQ36362008-02FDDC19-88A7-4B36-934B-676B91AA5DF5Q36441711-CE31DFB1-2036-4EB1-9EB5-D89EE75EEF39Q36482537-CB77B58D-F7B4-498F-A077-C60B7B252D03Q36549150-896F6A3D-ADC9-4BB2-A3A4-F5934E5F0688Q36611020-3643DBDF-593F-4256-B5CA-80FC6FAE7B19Q36911367-A72CD7D7-0C91-4C88-BF58-11A52E7D971BQ36999970-056349BD-C663-43E1-A120-354F6ECBC419
P2860
Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation.
description
1992 nî lūn-bûn
@nan
1992 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Treatment with intravitreal st ...... e to retinal photocoagulation.
@ast
Treatment with intravitreal st ...... e to retinal photocoagulation.
@en
type
label
Treatment with intravitreal st ...... e to retinal photocoagulation.
@ast
Treatment with intravitreal st ...... e to retinal photocoagulation.
@en
prefLabel
Treatment with intravitreal st ...... e to retinal photocoagulation.
@ast
Treatment with intravitreal st ...... e to retinal photocoagulation.
@en
P2093
P1433
P1476
Treatment with intravitreal st ...... e to retinal photocoagulation.
@en
P2093
P304
P356
10.1001/ARCHOPHT.1992.01080200135041
P407
P577
1992-08-01T00:00:00Z